Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Zittermann A, Berthold HK, Pilz S. The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2020;74:1–8.

    Google Scholar 

  2. 2.

    Lerch C, Shroff R, Wan M, Rees L, Aitkenhead H, Kaplan Bulut I, et al. Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease. Nephrol Dial Transpl. 2018;33:2208–17.

    CAS  Article  Google Scholar 

  3. 3.

    Carpenter TO, Olear EA, Zhang JH, Ellis BK, Simpson CA, Cheng D, et al. Effect of paricalcitol on circulating parathyroid hormone in X-linked hypophosphatemia: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2014;99:3103–11.

    CAS  Article  Google Scholar 

  4. 4.

    Alvarez JA, Law J, Coakley KE, Zughaier SM, Hao L, Shahid Salles K, et al. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2012;96:672–9.

    CAS  Article  Google Scholar 

  5. 5.

    Bhan I, Dobens D, Tamez H, Deferio JJ, Li YC, Warren HS, et al. Nutritional vitamin D supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol. 2015;10:611–9.

    CAS  Article  Google Scholar 

  6. 6.

    Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens. 2012;25:1215–22.

    CAS  Article  Google Scholar 

  7. 7.

    Larsen T, Mose FH, Bech JN, Pedersen EB. Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial. BMC Nephrol. 2013;14:163.

    CAS  Article  Google Scholar 

  8. 8.

    Turrini F, Scarlini S, Giovanardi P, Messora R, Roli L, Chester J, et al. Effects of Cholecalciferol Supplementation in Patients with stable heart failure and LOw vITamin D levels (ECSPLOIT-D): a double-blind, randomized, placebo-controlled pilot study. Minerva Cardioangiol. 2017;65:553–62.

    PubMed  Google Scholar 

  9. 9.

    Sprague SM, Crawford PW, Melnick JZ, Strugnell SA, Ali S, Mangoo-Karim R, et al. Use of extended-release calcifediol to treat secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Am J Nephrol. 2016;44:316–25.

    CAS  Article  Google Scholar 

  10. 10.

    Macdonald HM, Wood AD, Aucott LS, Black AJ, Fraser WD, Mavroeidi A, et al. Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1‐year double‐blind RCT in postmenopausal women. J Bone Min Res. 2013;28:2202–13.

    CAS  Article  Google Scholar 

  11. 11.

    Higgins JPTGS, editor. 16.5.4 How to include multiple, for gfosIICh, systematic reviews of interventions vTC, from: CcDA, https://handbook-5-1.cochrane.org/chapter_16/16_5_4_how_to_, include_multiple_groups_from_one_study.htm.

  12. 12.

    Trummer C, Schwetz V, Pandis M, Grübler MR, Verheyen N, Gaksch M, et al. Effects of vitamin D supplementation on FGF23: a randomized-controlled trial. Eur J Nutr. 2019;58:697–703.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Contributions

The authors’ responsibilities were as follows: FM, SS, and SA reviewed the article and discovered errors. SA wrote the letter, and ZSC provided critical review. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Shima Abdollahi.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Meshkini, F., Soltani, S., Clayton, Z.S. et al. The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr (2021). https://doi.org/10.1038/s41430-021-00903-8

Download citation

Search

Quick links